LetterEtanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection
References (5)
- et al.
The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocytes) and Th1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients
J Invest Dermatol
(1999) - et al.
Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study
J Hepatol
(2005)
There are more references available in the full text version of this article.
Cited by (45)
Psoriasis: Which therapy for which patient: Focus on special populations and chronic infections
2019, Journal of the American Academy of DermatologyRisk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature
2017, Journal of the American Academy of DermatologyCitation Excerpt :Sample sizes ranged from 1 to 62, with a total of 803.48 reported patient-years: HCV infected patients accounted for 123.83 patient-years, chronic HBV infected patients accounted for 57.46 patient-years, and patients positive for HBcAb accounted for 622.19 patient-years. The complete list of included studies appears in Appendix I (Supplemental Table I; available at http://www.jaad.org).13-60 Table V13-60 summarizes the main characteristics of the included studies, and Table VI summarizes the reports describing viral reactivation during biologic therapy.
Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part II. Screening for patients on tumor necrosis factor-alfa antagonists
2014, Journal of the American Academy of DermatologyEtanercept and chronic infection by HCV and HBV
2010, Actas Dermo-Sifiliograficas
Copyright © 2006 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.